
Auxillo Pharma Private Limited
About Auxillo Pharma Private Limited
Data last updated:
Auxillo Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 11 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2019PTC186601. Its GSTIN is 27AASCA7177R1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chaya Anil Hanwante and Aakrutee Hriday Narayan Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gat No – 690 To 710 Flat No. C/705 Umang Premier Hadpsar, Pune, Maharashtra, India – 412207.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.44 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹2.97 Lakh (net margin -22.1%) and EBITDA of -₹2.7 Lakh (EBITDA margin -20.1%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
Company details
Contact details
Auxillo Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressGat No – 690 To 710 Flat No. C/705 Umang Premier Hadpsar, Pune, Maharashtra, India – 412207
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Auxillo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Auxillo Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Auxillo Pharma Private Limited, buy the company report.
Financials of Auxillo Pharma Private Limited
FY 2025 filings availableAuxillo Pharma Private Limited reported revenue of ₹13.44 Lakh (down 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over three years, including a 35% fall in the latest year. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -20.1% | ||||
| Net Profit Margin | -22.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Auxillo Pharma Private Limited, buy the company report.
Board of directors of Auxillo Pharma Private Limited
Auxillo Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chaya Anil Hanwante | Director | 11 Sep 2019 | 7 Years 1 Months | Current |
| Aakrutee Hriday Narayan Mishra | Director | 11 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Auxillo Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Harmeda Healthcare Private Limited | ₹13.98 Lakh (FY 2025) | Mohali, Punjab, India | ||||
| Mindswift Pharmaceuticals Private Limited | ₹13.97 Lakh (FY 2025) | 35.0% | Pune, Maharashtra, India | |||
| Dr. Memon Lab Private Limited | ₹13.9 Lakh (FY 2025) | 44.0% | Patna, Bihar, India | |||
| Dawas Health Private Limited | ₹13.85 Lakh (FY 2023) | 60.0% | Delhi, India | |||
| Medterm Healthcare Private Limited | ₹13.56 Lakh (FY 2024) | -20.0% | Bangalore, Karnataka, India | |||
| Auxillo Pharma Private Limitedthis company | ₹13.44 Lakh (FY 2024) | -₹2.97 Lakh | -22.1% | -35.0% | Pune, Maharashtra, India | |
| Kush Impex Private Limited | ₹13.23 Lakh (FY 2024) | 417.0% | Nagpur, Maharashtra, India | |||
| Mcvlaboratory Private Limited | ₹13.23 Lakh (FY 2025) | -27.0% | Vadodara, Gujarat, India | |||
| Zissis Pharmaceutical Private Limited | ₹13.13 Lakh (FY 2025) | -38.0% | Ghaziabad, Uttar Pradesh, India | |||
| Seventytwopharma Omnicare Private Limited | ₹13.02 Lakh (FY 2025) | 491.0% | Karaikudi, Tamil Nadu, India | |||
| Sea Science Pharmaceutical Private Limited | ₹12.97 Lakh (FY 2024) | 166.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Auxillo Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Auxillo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Auxillo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Auxillo Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AASCA7177R1ZH | Maharashtra | Active | 27 Nov 2019 |
To see the full GST registrations and return filing status of Auxillo Pharma Private Limited, buy the company report.
Recent activity
Auxillo Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Aakrutee Hriday Narayan Mishra was appointed as Director on 11 Sep 2019.
Frequently asked questions
Auxillo Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 11 September 2019 (7+ years old) and is registered under CIN U24230PN2019PTC186601.
Auxillo Pharma has 2 current directors:
- Chaya Anil Hanwante - Director
- Aakrutee Hriday Narayan Mishra - Director
The latest financial statements of Auxillo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Auxillo Pharma is 27AASCA7177R1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Auxillo Pharma is U24230PN2019PTC186601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auxillo Pharma was incorporated on 11 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Auxillo Pharma by revenue are Harmeda Healthcare Private Limited, Mindswift Pharmaceuticals Private Limited, Dr. Memon Lab Private Limited, Dawas Health Private Limited, Medterm Healthcare Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Aakrutee Hriday Narayan Mishra was appointed as Director on 11 Sep 2019. Chaya Anil Hanwante was appointed as Director on 11 Sep 2019.
The registered office of Auxillo Pharma is at Gat No – 690 To 710 Flat No. C705 Umang Premier Hadpsar, Pune, Maharashtra, India – 412207.
Auxillo Pharma operates in the chemicals industry, in the other chemical product segment.
Auxillo Pharma can be reached at its registered office: Gat No – 690 To 710 Flat No. C705 Umang Premier Hadpsar, Pune, Maharashtra, India – 412207.

